Asahi Kasei Pharma Denmark A/S: Financial statements 2022
CVR: 40948074
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
Asahi Kasei Pharma Denmark A/S (CVR 40948074) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,216,585 and a net result of DKK 4,670,489. Equity in the 2022 report amounted to DKK 907,659,881. The solvency ratio was 99.5%.
- Gross Profit
- DKK -1,216,585
- Profit/Loss
- DKK 4,670,489
- Equity
- DKK 907,659,881
- Total Assets
- DKK 912,639,298
- Employees
- 0
Official annual report
Keep an eye on Asahi Kasei Pharma Denmark A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Asahi Kasei Pharma Denmark A/S
Asahi Kasei Pharma Denmark A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named River Forest A/S. The management consists of Daisuke Matsuo. The board consists of Masaya Etoh (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -793,488 and a net result of DKK 25,833,192 compared with DKK 26,072,771 the year before. Equity in the 2026 report amounted to DKK 1,003,291,531.
